NASONEX 50 micrograme/doza Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

nasonex 50 micrograme/doza

organon heist bv - belgia - mometasonum - spray naz.,susp. - 50micrograme/doza - decongestionante si alte medicamente nazale de uz topic corticosteroidiene

NASONEX® Brasiilia - portugali - ANVISA (Agência Nacional de Vigilância Sanitária)

nasonex®

organon farmacÊutica ltda. - furoato de mometasona monoidratado - produtos para terapia nasal de acao especifica

Nasonex Erogazione Spray Nasale Šveits - itaalia - Swissmedic (Swiss Agency for Therapeutic Products)

nasonex erogazione spray nasale

organon gmbh - mometasoni-17 furoas - erogazione spray nasale - mometasoni-17 furoas 0.5 mg, cellulosum microcristallinum et carmellosum natricum, glycerolum, acidum citricum monohydricum, natrii citras dihydricus, polysorbatum 80, benzalkonii chloridum 0.2 mg, aqua purificata, ad suspensionem pro 1 g corresp., mometasoni-17 furoas 50 µg pro dosi, doses pro vase 140. - rinite, nasenpolypen - synthetika

Nasonex Dosage Spray Nasal Šveits - prantsuse - Swissmedic (Swiss Agency for Therapeutic Products)

nasonex dosage spray nasal

organon gmbh - mometasoni-17 furoas - dosage spray nasal - mometasoni-17 furoas 0.5 mg, cellulosum microcristallinum et carmellosum natricum, glycerolum, acidum citricum monohydricum, natrii citras dihydricus, polysorbatum 80, benzalkonii chloridum 0.2 mg, aqua purificata, ad suspensionem pro 1 g corresp., mometasoni-17 furoas 50 µg pro dosi, doses pro vase 140. - rhinite, nasenpolypen - synthetika

Nasonex Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

nasonex

organon (new zealand) limited - mometasone furoate monohydrate 51.7ug equivalent to 50 mcg mometasone furoate - nasal spray solution - 50 mcg/dose - active: mometasone furoate monohydrate 51.7ug equivalent to 50 mcg mometasone furoate excipient: benzalkonium chloride citric acid monohydrate dispersible cellulose glycerol polysorbate 80 purified water sodium citrate dihydrate - nasonex nasal spray is indicated for the treatment of symptoms associated with seasonal allergic rhinitis and perennial allergic rhinitis and the prophylaxis of seasonal allergic rhinitis inadults, adolescents and children between the ages of 3 and 11 years.

NASONEX NASPR.SUS 0,05% W/W Kreeka - kreeka - Εθνικός Οργανισμός Φαρμάκων

nasonex naspr.sus 0,05% w/w

n.v. organon holland kloosterstraat 6, 5349 ab oss - mometasone furoate monohydrate (micronised) - naspr.sus (ΡΙΝΙΚΟ ΕΚΝΕΦΩΜΑ, ΕΝΑΙΩΡΗΜΑ) - 0,05% w/w - mometasone furoate monohydrate (micronised) 0,5mg - mometasone

Nasonex Nefúði, dreifa 50 míkróg/skammt Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

nasonex nefúði, dreifa 50 míkróg/skammt

n.v. organon* - mometasonum fúróat - nefúði, dreifa - 50 míkróg/skammt